Latest Security News

West Coast Silver has raised over $6 million through a share placement to accelerate exploration at its high-grade Elizabeth Hill silver project, signalling strong investor confidence and ambitious growth plans.

EQ Resources Limited highlighted its growing global footprint in tungsten mining at the 2025 Noosa Mining Conference, detailing production growth, reserve expansions, and strategic funding initiatives.

Kinetiko Energy has begun drilling a key production test well in South Africa, advancing its transition from exploration to gas production with plans for a pilot LNG plant by late 2026.

Catalyst Metals reported steady gold production in the June 2025 quarter, progressing development at its Trident project while completing key corporate transactions that strengthen its growth outlook.

Merchant House International has completed the sale of its American Merchant, Inc. assets, generating significant profits and setting the stage for winding up operations and voluntary delisting from the ASX.

Future Battery Minerals Ltd has acquired 100% ownership of the Miriam Project, extinguishing royalties and advancing multiple high-priority gold targets with initial drilling completed. Assay results are expected in early September 2025.

InVert Graphite Limited has successfully raised $3.5 million and resumed ASX trading following key acquisitions and promising initial trench results at its Morogoro Graphite Project.

Bioxyne Limited reports a record-breaking Q4 FY25 with revenue soaring 204% year-on-year and a strategic entry into the German market through a €3.2 million manufacturing agreement.

Novonix Limited reports significant progress in its synthetic graphite anode materials production, benefiting from new US tariffs on Chinese imports and strategic leadership appointments. The company also secures up to US$100 million in convertible debenture funding to support expansion plans.

Catalyst Metals has locked in a three-year A$100 million revolving credit facility with major banks, bolstering its financial flexibility without immediate debt drawdown. This move strengthens its balance sheet as it advances development at the Plutonic Gold Belt.

NOVONIX has entered a multi-tranche funding agreement with Yorkville Advisors to raise up to US$100 million through convertible debentures, supporting its Riverside facility build-out and commercial production ramp-up.

Island Pharmaceuticals reported promising Phase 2a/b trial results for its dengue drug ISLA-101 and secured a strategic acquisition of the broad-spectrum antiviral Galidesivir, bolstering its pipeline and balance sheet.